Chris Kotanidis
cpkotanidis.bsky.social
Chris Kotanidis
@cpkotanidis.bsky.social
35 followers 28 following 10 posts
Editorial Fellow at New England Journal of Medicine | PostDoc at Harvard Med | DPhil University of Oxford | MD Aristoteleio
Posts Media Videos Starter Packs
Reposted by Chris Kotanidis
#ZakKohane on #AI in #PeerReview: the surge in scientific publication is straining the conventional review system beyond capacity. @ai.nejm.org piloting AI-augmented fast track review: manuscripts w high prior of being good gets assigned to #GPT5 + a human, disposition reviewed by editorial team!
Reposted by Chris Kotanidis
Comparing submitted vs published RCT abstracts eval'd at @nejm.org in 4 domains (design, outcome, AEs, conclusions). published abstracts improved in a mean 0.9 domains. More improvements observed in leading gen med vs 433 other journals (72 % vs 48%) www.acpjournals.org/...
@cpkotanidis.bsky.social
Excited to present our work tomorrow on a novel #AI #metabolomics score to predict #cardiovascular risk in #psoriasis at the #ESCCongress #WCCardio 2025 Young Investigator Award session in Preventive Cardiology. #PreventiveCardiology #CardioRheumatology #YIA
Reposted by Chris Kotanidis
NEJM.org @nejm.org · Aug 29
Four Original Articles were simultaneously published in NEJM and presented earlier today at this year’s #ESCCongress in Spain.

@escardio.bsky.social
Reposted by Chris Kotanidis
The #1 cause of death in women is heart disease. A new report makes the case for treating women with statins who have a high inflammation marker (hs-CRP) but no traditional risk factors academic.oup.com/eurheartj/ad...
Reposted by Chris Kotanidis
🎥 Snackable Science from #ESCCongress 2025 in Madrid!

Roxana Mehran & Michael Gibson break down the new Focus Update of the 2019 #ESCGuidelines on #dyslipidaemias with the latest recommendations you need to know 👇
Reposted by Chris Kotanidis
NEJM.org @nejm.org · Aug 15
For a man with #obesity, would you recommend the initiation of semaglutide therapy or bariatric and metabolic surgery? Read the case vignette and essays on both treatment options and cast your vote: nej.md/3HiAnJz

#MedSky #EndoSky
The win ratio method is gaining traction in #RCTs. Is it just a trend or a smarter way to look at composite hierarchical outcomes? We break it down in our latest Stats, STAT!📊 in NEJM Evidence. youtube.com/watch?v=jKtF... #stats @nejm.org @sarahgorey.bsky.social @chardin.bsky.social @ai.nejm.org
How Win Ratios Work | NEJM Evidence
YouTube video by NEJM Group
youtube.com
Reposted by Chris Kotanidis
1/ 🚨 NEW #BeyondJournalClub w/ @nejm.org: REDUCE-AMI

What is the long term benefit of beta blockers in patients with preserved EF following an MI?

🖥️: www.coreimpodcast.com/2025/06/25/b...
Reposted by Chris Kotanidis
In older patients with acute coronary syndrome, an early invasive strategy did not reduce all-cause mortality but decreased recurrent myocardial infarction and repeated revascularization. https://ja.ma/40hDK9G
Reposted by Chris Kotanidis
NEJM.org @nejm.org · Jun 13
What is it like to be an NEJM editorial fellow for a year? This year’s fellows discuss what they have learned, how their experience will help their career, and what surprised them. Apply for the 2026–27 NEJM editorial fellowship by August 1. Learn more: nej.md/3cCQajB

#MedSky #MedEd
Reposted by Chris Kotanidis
NEJM.org @nejm.org · Jun 14
60-Second Journal Club: The SUMMIT trial examined cardiovascular outcomes of treatment with tirzepatide in patients with heart failure with preserved ejection fraction and obesity. Read the full trial results: nej.md/4hRGaTY

#MedSky #CardioSky @cpkotanidis.bsky.social
Reposted by Chris Kotanidis
NEJM.org @nejm.org · Jun 9
A 73-year-old woman presented with severe chest pain. She had undergone multivessel percutaneous coronary intervention 2.5 years earlier. Angiography revealed a large thrombus in an LAD artery stent (shown in videos). Read the full case details: nej.md/4jC2aSa

#MedSky #CardioSky
Reposted by Chris Kotanidis
Really enjoying @cpkotanidis.bsky.social’s fascinating presentation on his interesting work at @brighamandwomens.bsky.social on identifying risk markers of CVD in patients with IMIDs 🤩👏👏👏
Reposted by Chris Kotanidis
NEJM.org @nejm.org · Mar 30
Presented at #ACC25:

In the PROTECT-TAVI trial, the routine use of cerebral embolic protection during TAVI did not reduce the incidence of stroke within 72 hours or before discharge from the hospital (if discharge occurred sooner). Full trial results: nej.md/41RONXi

@accintouch.bsky.social
Routine Cerebral Embolic Protection during Transcatheter Aortic-Valve Implantation | NEJM
Transcatheter aortic-valve implantation (TAVI) is associated with procedure-related stroke. Cerebral embolic protection (CEP) devices may reduce embolization to the cerebral circulation and hence t...
nej.md
Reposted by Chris Kotanidis
NEJM.org @nejm.org · Mar 8
Tirzepatide was previously shown to provide sustained weight reductions in adults with #obesity. Longer-term findings in adults with both obesity and prediabetes are summarized in a new Quick Take video. youtu.be/c9uazgSdDJc

#MedSky #EndoSky
- YouTube
Enjoy the videos and music you love, upload original content, and share it all with friends, family, and the world on YouTube.
youtu.be